GAD-alum

glutamic acid decarboxylase (GAD65) formulated with aluminum hydroxide · Diamyd Medical AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAD-alum, covering 2018-05-17 to 2018-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Diabetes Virus Detection Project, Intervention With GAD-alum [Phase 2]